Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Jarushka Naidoo
Aug 5, 2024, 01:55 |
Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Aug 1, 2024, 13:27 |
Blog
Rahul Gosain: How will the data from WCLC24 impacts our day to day clinical practice
Rahul Gosain shared a post on LinkedIn: "WCLC24 ~5 weeks away! Let discuss the current…
Aug 1, 2024, 07:01 |
Blog
Advice for young oncologists from Balazs Halmos
Jarushka Naidoo shared a post on X: ''Stay Curious, Remain Humble: An Oncologist’s Advice to…
Jul 30, 2024, 06:39 |
Insight
Ph II KUPENG trial of Vebreltinib in Advanced MetExon14 and NSCLC
Jarushka Naidoo shared a post on X about a recent paper by Jin-Ji Yang et…
Jul 22, 2024, 02:59 |
Blog
CtDNA Analysis on Osimertinib in FLAURA and AURA3 trials
Jarushka Naidoo shared a post on X about an article by Jhanelle Gray et al. titled…
Jul 21, 2024, 20:02 |
Blog
Biagio Ricciuti: Join us in Lausanne for the 2024 International Lung Cancer Summit
Biagio Ricciuti shared a post on X by the International Lung Cancer Summit, adding: "Join…
Jul 7, 2024, 15:44 |
Blog
Francesco Cortiula: What evidences for the treatment of patients with stage III NSCLC excluded from trials?
Francesco Cortiula, Medical Oncologist at University Hospital of Udine, made the following post on X:…
Jun 19, 2024, 03:23 |
Blog
Alessio Cortellini: A great honor to be invited to the amazing Tbilisi to discuss irAEs-management
Alessio Cortellini, Assistant Professor at Campus Bio-Medico University of Rome, shared a post on LinkedIn: …
Jun 18, 2024, 18:00 |
Insight
Elene Mariamidze: The ESMO reunion in Tbilisi, Georgia
Elene Mariamidze, Medical/Clinical Oncologist at Todua Clinic, shared the following post on X: “The ESMO…
Jun 10, 2024, 11:09 |
Insight
Phase II BLOSSOM Trial Osimertinib in LMD from EGFR+ NSCLC by Sehhoon Park et al.
Jarushka Naidoo shared a post on X: "Phase II BLOSSOM Trial Osimertinib in LMD (leptomeningeal…
5
6
7
8
9
All:
86
Posts:
61 - 70
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube